Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujing Xu

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Journal of Medicinal Chemistry|December 6, 2023
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid ModulatorsShujing Xu, Lin Sun, Michael Barnett, et al.
Journal of Medicinal Chemistry|April 17, 2020
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral ActivitiesLin Sun, Alexej Dick, Megan E Meuser, et al.
Medcomm|May 6, 2026
Discovery of 4-Quinazolinone-Containing Phenylalanine Derivatives as Potent, Resistant-Tolerant HIV Capsid InhibitorsXujie Zhang, Lin Sun, Laura Walsham, et al.
European Journal of Medicinal Chemistry|October 15, 2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stabilityShujing Xu, Lin Sun, Alexej Dick, et al.
Journal of Medicinal Chemistry|September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low ToxicityShenghua Gao, Katharina Sylvester, Letian Song, et al.
Nature Communications|August 11, 2025
Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimizationZhijiao Zhang, Xiaoyu Shi, Ting Wu, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Journal of Medicinal Chemistry|December 6, 2023
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid ModulatorsShujing Xu, Lin Sun, Michael Barnett, et al.
Journal of Medicinal Chemistry|April 17, 2020
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral ActivitiesLin Sun, Alexej Dick, Megan E Meuser, et al.
Medcomm|May 6, 2026
Discovery of 4-Quinazolinone-Containing Phenylalanine Derivatives as Potent, Resistant-Tolerant HIV Capsid InhibitorsXujie Zhang, Lin Sun, Laura Walsham, et al.
European Journal of Medicinal Chemistry|October 15, 2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stabilityShujing Xu, Lin Sun, Alexej Dick, et al.
Journal of Medicinal Chemistry|September 15, 2022
Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low ToxicityShenghua Gao, Katharina Sylvester, Letian Song, et al.
Nature Communications|August 11, 2025
Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimizationZhijiao Zhang, Xiaoyu Shi, Ting Wu, et al.
Pageof 11